Published February 2021
| Version v1
Journal article
Myocardial T1 mapping and extracellular volume quantification as novel biomarkers in risk stratification of patients with systemic sclerosis
- 1. Department of Imaging and Pathology, University Hospitals Leuven, Leuven (Belgium)
- 2. Department of Rheumatology, University Hospitals Leuven, Leuven (Belgium)
Description
Highlights: • Cardiac involvement in systemic sclerosis (SSc) is frequent. • Cardiac magnetic resonance (CMR) can be used to detect cardiac involvement in SSc. • Native T1 mapping and extracellular volume (ECV) are biomarkers for disease monitoring. To study the prognostic value of myocardial native T1 and extracellular volume (ECV), measured by cardiovascular magnetic resonance (CMR), in patients with systemic sclerosis (SSc).
Availability note (English)
Available from http://dx.doi.org/10.1016/j.crad.2020.09.023Additional details
Identifiers
- DOI
- 10.1016/j.crad.2020.09.023;
- PII
- S0009926020304384;
Publishing Information
- Journal Title
- Clinical Radiology
- Journal Volume
- 76
- Journal Issue
- 2
- Journal Page Range
- p. 162.e1-162.e8
- ISSN
- 0009-9260
- CODEN
- CLRAAG
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 53113059
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BIOLOGICAL MARKERS; CHEST; DISEASES; NMR IMAGING; PATIENTS
- Descriptors DEC
- BODY; DIAGNOSTIC TECHNIQUES
Optional Information
- Copyright
- Copyright (c) 2020 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.